Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rotavirus, quantity: 1000000 ccid50/dose - oral liquid, suspension - excipient ingredients: sucrose; water for injections; adipic acid; sodium hydroxide; glucose monohydrate; sodium chloride; potassium chloride; magnesium sulfate heptahydrate; ferric nitrate nonahydrate; dibasic sodium phosphate dihydrate; sodium pyruvate; folic acid; calcium pantothenate; inositol; choline chloride; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; riboflavine; cystine; tyrosine; arginine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan; serine; valine; glutamine; calcium chloride dihydrate; sodium bicarbonate - rotarix is indicated for the prevention of rotavirus gastroenteritis (see clinical trials).

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rotavirus, quantity: 1000000 ccid50/dose - oral liquid, suspension - excipient ingredients: sucrose; water for injections; adipic acid; sodium hydroxide; glucose monohydrate; sodium chloride; potassium chloride; magnesium sulfate heptahydrate; ferric nitrate nonahydrate; dibasic sodium phosphate dihydrate; sodium pyruvate; folic acid; calcium pantothenate; inositol; choline chloride; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; riboflavine; cystine; tyrosine; arginine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan; serine; valine; glutamine; calcium chloride dihydrate; sodium bicarbonate - rotarix is indicated for the prevention of rotavirus gastroenteritis (see clinical trials).

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bovine herpesvirus 1 - topical aerosol spray - bovine herpesvirus 1 vaccine-viral active 0.0 p - immunotherapy - cattle - feedlot | beef | bovine | dairy cow - bovine herpesvirus | promote animal growth | feed conversion | finishing | growth promotion | growth rate | liveweight gain

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

merial animal health limited - inactivated bovine respiratory syncytial virus, strain bio-24, inactivated bovine parainfluenza 3 virus, strain bio-23, inactivated mannheimia (pasteurella) haemolyica, a1 strain dsm 5283 - suspension for injection - . - inactivated viral and inactivated bacterial vaccines - cattle - immunological - inactivated vaccine

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

merial animal health limited - inactivated bovine respiratory syncytial virus, strain bio-24, inactivated bovine parainfluenza 3 virus, strain bio-23, inactivated mannheimia haemolytica serotype a1 strain dsm 5283, inactivated bovine viral diarrhoea virus, strain bio-25 - suspension for injection - . - inactivated viral and inactivated bacterial vaccines - cattle - immunological - inactivated vaccine

Estats Units - anglès - NLM (National Library of Medicine)

teva women's health, inc. - human adenovirus e serotype 4 strain cl-68578 (unii: fkd3duk39i) (human adenovirus e serotype 4 strain cl-68578 - unii:fkd3duk39i) - human adenovirus e serotype 4 strain cl-68578 32000 [tcid_50] - adenovirus type 4 and type 7 vaccine, live, oral is a vaccine indicated for active immunization for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7. adenovirus type 4 and type 7 vaccine, live, oral is approved for use in military populations 17 through 50 years of age. adenovirus type 4 and type 7 vaccine, live, oral should not be administered to pregnant females [see pregnancy (8.1)] . it is not known whether adenovirus type 4 and type 7 vaccine, live, oral can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. naturally occurring infection with adenoviruses has been associated with fetal harm. pregnancy should be avoided for 6 weeks following receipt of vaccine. severe allergic reaction (e.g., anaphylaxis) to any component of adenovirus type 4 and type 7 vaccine, live, oral is a contraindication [see description (11)]. adenovirus type 4 and type 7 vaccine, live, oral should not be administered to individuals incapable of swa

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - bovine herpes virus type 1 (bhv-1), strain difivac - suspension for injection - . - bovine rhinotracheitis virus (ibr) - cattle - immunological - inactivated vaccine

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - inactivated bovine respiratory syncytial virus, strain bio-24; inactivated bovine parainfluenza 3 virus, strain bio-23; inactivated mannheimia (pasteurella) haemolyica, a1 strain dsm 5283 - suspension for injection - . - inactivated viral and inactivated bacterial vaccines

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - inactivated bovine respiratory syncytial virus, strain bio-24; inactivated bovine parainfluenza 3 virus, strain bio-23; inactivated mannheimia haemolytica serotype a1 strain dsm 5283; inactivated bovine viral diarrhoea virus, strain bio-25 - suspension for injection - . - inactivated viral and inactivated bacterial vaccines

Eslovènia - anglès - HMA (Heads of Medicines Agencies)

pfizer animal health - bovine parainfluenza 3 virus (pi3), rlb103, attenuated 10 ml, bovine respiratory syncytial virus (brsv), strain 375 attenuated 10 ml - injection - cattle - bovine respiratory syncytial virus vaccine + bovine parainfluenza virus vaccine